Multiple Aspects of the Toxicity of Fluroxene and its Metabolite 2,2,2-Trifluoroethanol

References

• Krantz J. C., Jr., Carr C. J., Lu G., Bell F. K. Anesthesia. XL. The anesthetic action of trifluoroethyl vinyl ether. J. Pharmacol. Exp. Ther. 1953; 108: 488
   PubMed Web of Science ®Google Scholar
• Fiserova Bergerova V. Metabolism and toxicity of 2,2,2-trifluoroethyl vinyl ether. Environ. Health Perspect. 1977; 21: 225
   PubMed Web of Science ®Google Scholar
• Bradshaw J. J., Ivanetich K. M. Isoflurane: a comparison of its metabolism by human and rat hepatic cytochrome P-450. Anesth. Analg. 1984; 63: 805
   PubMed Web of Science ®Google Scholar
• Hitt B. A., Mazze R. I., Cousins M. J., Edmuns H. N., Barr G. A., Trudell J. R. Metabolism of isoflurane in Fischer 344 rats and man. Anesthesiology 1974; 40: 62
   PubMed Web of Science ®Google Scholar
• Maiorino R. M., Gandolfi A. J., Sipes I. G. Gas-chromatographic method for the halothane metabolites, trifluoroacetic acid and bromide, in biological fluids. J. Anal. Toxicol. 1980; 4: 250
   PubMed Web of Science ®Google Scholar
• Van Stee E. W. Toxicology of inhalation anesthetics and metabolites. Annu. Rev. Pharmacol. Toxicol. 1976; 16: 67
   PubMed Web of Science ®Google Scholar
• Corbett T. H. Pharmacology and toxicology of halogenated anesthetics. Adv. Pharmacol. Chemother. 1979; 16: 195
   PubMedGoogle Scholar
• Holaday D. A., Fiserova Bergerova V. Fate of fluorinated metabolites of inhalation anesthetics in man. Drug Metab. Rev. 1979; 9: 61
   PubMed Web of Science ®Google Scholar
• Vaughan R. W., Sipes I. G., Brown B. R., Jr. Role of biotransformation in the toxicity of inhalation anesthetics. Life Sci. 1978; 23: 2447
   PubMed Web of Science ®Google Scholar
• Cohen E. N. Metabolism of the volatile anesthetics. Anesthesiology 1971; 35: 193
   PubMed Web of Science ®Google Scholar
• Geddes I. C. Metabolism of volatile anaesthetics. Br. J. Anaesth. 1972; 44: 953
   PubMed Web of Science ®Google Scholar
• Cascorbi H. F. Biotransformation of drugs used in anesthesia. Anesthesiology 1973; 39: 115
   PubMed Web of Science ®Google Scholar
• Fiserova Bergerova V., Holaday D. A. Uptake and clearance of inhalation anesthetics in man. Drug Metab. Rev. 1979; 9: 43
   PubMed Web of Science ®Google Scholar
• Brown B. R., Jr., Vandam L. D. A review of current advances in metabolism of inhalation anesthetics. Ann. N.Y. Acad. Sci. 1971; 179: 235
   PubMed Web of Science ®Google Scholar
• Blake D. A., Cascorbi H. F. A note on the biotransformation of fluroxene in two volunteers. Anesthesiology 1970; 32: 560
   PubMed Web of Science ®Google Scholar
• Cascorbi H. F., Blake D. A. Trifluoroethanol and halothane biotransformation in man. Anesthesiology 1971; 35: 493
   PubMed Web of Science ®Google Scholar
• Creasser C., Stoelting R. K. Serum inorganic fluoride concentrations during and after halothane, fluroxene, and methoxyflurane anesthesia in man. Anesthesiology 1973; 39: 537
   PubMed Web of Science ®Google Scholar
• Gion H., Yoshimura N., Holaday D. A., Fiserova Bergerova V., Chase R. E. Biotransformation of fluroxene in man. Anesthesiology 1974; 40: 553
   PubMed Web of Science ®Google Scholar
• Blake D. A., Rozman R. S., Cascorbi H. F., Krantz J. C., Jr. Anesthesia. LXXIV. Biotransformation of fluroxene. I. Metabolism in mice and dogs in vivo. Biochem. Pharmacol. 1967; 16: 1237
   PubMed Web of Science ®Google Scholar
• Ivanetich K. M., Bradshaw J. J., Marsh J. A., Harrison G. G., Kaminsky L. S. The role of cytochrome P-450 in the toxicity of fluroxene (2,2,2-trifluoroethyl vinyl ether) anaesthesia in vivo. Biochem. Pharmacol. 1976; 25: 773
   PubMed Web of Science ®Google Scholar
• Munson E. S., Malagodi M. H., Shields R. P., Tham M. K., Fiserova Bergerova V., Holaday D. A., Perry J. C., Embro W. J. Fluroxene toxicity induced by phenobarbital. Clin. Pharmacol. Ther. 1975; 18: 687
   PubMed Web of Science ®Google Scholar
• Ivanetich K. M., Bradshaw J. J., Marsh J. A., Kaminskv L. S. The interaction of hepatic microsomal cytochrome P-450 with fluroxene (2,2,2-trifluoroethyl vinyl ether) in vitro. Biochem. Pharmacol. 1976; 25: 779
   PubMed Web of Science ®Google Scholar
• Marsh J. A., Ivanetich K. M., Bradshaw J. J., Harrison G. G., Webber B. L., Kaminskv L. S. An investigation into the hepatic cytochrome P-450 catalysed metabolism of the anaesthetic fluroxene (2,2,2-trifluoroethyl vinyl ether). S. Afr. J. Med. Sci. 1975; 40: 205
   PubMedGoogle Scholar
• Marsh J. A., Bradshaw J. J., Sapeika G. A., Lucas S. A., Kaminsky L. S., Ivanetich K. M. Further investigations of the metabolism of fluroxene and the degradation of cytochromes P-450 in vitro. Biochem. Pharmacol. 1977; 26: 1601
   PubMed Web of Science ®Google Scholar
• Murphy M. J., Dunbar D. A., Guengerich F. P., Kaminsky L. S. Destruction of highly purified cytochromes P-450 associated with metabolism of fluorinated ether anesthetics. Arch. Biochem. Biophys. 1981; 212: 360
   PubMed Web of Science ®Google Scholar
• Murphy M. J., Dunbar D. A., Kaminsky L. S. Acute toxicity of fluorinated ether anesthetics: role of 2,2,2-trifluoroethanol and other metabolites. Toxicol. Appl. Pharmacol. 1983; 71: 84
   PubMed Web of Science ®Google Scholar
• Graves P. E., Kaminsky L. S., Halpert J. Evidence for functional and structural multiplicity of pregnenolone-16-α-carbonitrile-inducible cytochrome P-450 isozymes in rat liver microsomes. Biochemistry 1987; 26: 3887
   PubMed Web of Science ®Google Scholar
• Blake D. A., Cascorbi H. F., Rozman R. S., Meyer F. J. Animal toxicity of 2,2,2-trifluoroethanol. Toxicol. Appl. Pharmacol. 1969; 15: 83
   PubMed Web of Science ®Google Scholar
• Airaksinen M. M., Kurki M., Rosenberg P. H., Idanpaan Heikkila J. E., Walker K. Distribution and fate of trifluoroethanol in rats. Ann. Med. Exp. Biol. Fenn. 1971; 49: 79
   PubMedGoogle Scholar
• Fraser J. M., Kaminsky L. S. Metabolism of 2,2,2-trifluoroethanol and its relationship to toxicity. Toxicol. Appl. Pharmacol. 1987; 89: 202
   PubMed Web of Science ®Google Scholar
• Fraser J. M., Kaminsky L. S. 2,2,2-Trifluoroethanol intestinal and bone marrow toxicity: the role of its metabolism to 2,2,2-trifluoroacetaldehyde and trifluoroacetic acid. Toxicol. Appl. Pharmacol. 1988, in press
   PubMed Web of Science ®Google Scholar
• Airaksinen M. M., Rosenberg P. H., Tammisto T. A possible mechanism of toxicity of trifluoroethanol and other halothane metabolites. Acta Pharmacol. Toxicol. (Copenhagen) 1970; 28: 299
   PubMedGoogle Scholar
• Karashima D., Shigematsu A., Furukawa T. Esterificalion of trifluoroacetic acid with phenyldiazomethane for quantitative gas chrornatographic analysis. Methods involving separation from biological materials. J. Chromatogr. 1977; 130: 77
   PubMed Web of Science ®Google Scholar
• Hirokawa T., Takemi H., Kiso Y., Takiyama R., Morio M., Fujii K., Kikuchi H. Analytical isotachophoresis utilizing computer simulation. II. Assessment of optimum separation conditions for urinary trifluoroacetic acid metabolized from anaesthetic halothane. J. Chromatogr. 1984; 305: 429
   PubMed Web of Science ®Google Scholar
• Karashima D., Takahashi S., Shigematsu A., Furukawa T., Kuhara T. The gas chrornatographic mass spectrometric determination of trifluoroacetic acid in biological fluid. Application to halothane metabolism. Biomed. Mass. Spectrom. 1976; 3: 41
   PubMedGoogle Scholar
• Witte L., Nau H., Fuhrhop J. H., Doenicke A., Grote B. Quantitative analysis of trifluoroacetic acid in body fluids of patients treated with halothane. J. Chromatogr. 1977; 143: 329
   PubMed Web of Science ®Google Scholar
• Zumbiel M. A., Fiserova Bergerova V., Malinin T. I., Holaday D. A. Glutathione depletion following inhalation anesthesia. Anesthesiology 1978; 49: 102
   PubMed Web of Science ®Google Scholar
• Brandt M. R., Korshin J., Hansen A. P., Hummer L., Madsen S. N., Rygg I., Ken let H. Influence of morphine anaesthesia on the endocrine-metabolic response to open-heart surgery. Acta Anaesthesiol. Stand. 1978; 22: 400
   PubMed Web of Science ®Google Scholar
• Hitt B. A., Mazze R. I., Cousins M. J., Edmunds H. N., Barr G. A., Trudell J. R. Metabolism of isoflurane in Fisher 344 rats and man. Anesthesiology 1974; 40: 62
   PubMed Web of Science ®Google Scholar
• Dickenson C. J., Dickinson F. M. Inhibition by ethanol, acetaldehyde and trifluoroethanol of reactions catalysed by yeast and horse liver alcohol dehydrogenases. Biochem. J. 1978; 171: 613
   PubMed Web of Science ®Google Scholar
• Renzi F., Waud B. E. Partition coefficients of volatile anesthetics in Kreb's solution. Anesthesiology 1977; 47: 62
   PubMed Web of Science ®Google Scholar
• Kvassman J., Pettersson G. Effect of pH on the binding of decanoate and trifluoroethanol to liver alcohol dehydrogenase. Eur. J. Biochem. 1980; 103: 557
   PubMedGoogle Scholar
• Blair A. H., Vallee B. L. Some catalytic properties of human liver alcohol dehydrogenase. Biochemistry 1966; 5: 2026
   PubMed Web of Science ®Google Scholar
• Zemaitis M. A., Green F. E. Impairment of hepatic microsomal drug metabolism in the rat during daily disulfiram administration. Biochem. Pharmacol. 1976; 25: 1355
   PubMed Web of Science ®Google Scholar
• Ryan D. E., Kopp D. R., Thomas P. E., Coon M. J., Levin W. Evidence that isoniazid and ethanol induce the same microsomal cytochrome P-450 in rat liver, an isozyme homologous to rabbit liver cytochrome P-450 isozyme 3a. Arch. Biochem. Biophys. 1986; 246: 633
   PubMed Web of Science ®Google Scholar
• Koop D. R., Casazza J. P. Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monoxygenase of rabbit microsomes. J. Biol. Chem. 1985; 260: 13607
   PubMed Web of Science ®Google Scholar
• Koop D. R., Crump B. L., Nordblum G. D., Coon M. J. Immunochemical evidence for induction of the alcohol-oxidizing cytochrome P-450 of rabbit liver microsomes by diverse agents: ethanol, imidazole. trichloroethyiene, acetone, pyrazole, and isoniazid. Proc. Natl. Acad. Sci. U.S.A. 1985; 82: 4065
   PubMed Web of Science ®Google Scholar
• Feierman D. E., Cederbaum A. I. Inhibition of microsomal oxidation of ethanol by pyrazole and 4-methylpyrazole in vitro. Biochem. J. 1986; 239: 671
   PubMed Web of Science ®Google Scholar
• Holaday D. A. Biotransformation in man and clinical toxicity of volatile anesthetics. Acta Anaesthesiol. Belg. 1975; 23: 160
   PubMedGoogle Scholar
• Tucker W. K., Munson E. S., Holaday D. A., Fiserova Bergerova V., Turner B. M. Hepatorenal toxicity following fluroxene anesthesia. Anesthesiology 1973; 39: 104
   PubMed Web of Science ®Google Scholar
• Harris J. A., Cromwell T. H. Jaundice following fluroxene anesthesia. Anesthesiology 1972; 37: 462
   PubMed Web of Science ®Google Scholar
• Wollman S. B., Surks S. N. Case history number 75: hepatic damage after fluroxene anesthesia. Anesth. Analg. 1973; 52: 942
   PubMed Web of Science ®Google Scholar
• Reynolds E. S., Brown B. R., Jr., Vandam L. D. Massive hepatic necrosis after fluroxene anesthesia—a case of drug interaction. N. Engl. J. Med. 1972; 286: 530
   PubMed Web of Science ®Google Scholar
• Stevens W. C., Eger E. I., Joas T. A., Cromwell T. H., White A., Dolan W. M. Comparative toxicity of isoflurane, halothane, fluroxene and diethyl ether in human volunteers. Can. Anaesth. Soc. J. 1973; 20: 357
   PubMedGoogle Scholar
• Johnston R. R., Cromwell T. H., Eger E. L., II, Cullen D., Stevens W. C., Joas T. The toxicity of fluroxene in animals and man. Anesthesiology 1973; 38: 313
   PubMed Web of Science ®Google Scholar
• Sindelar W. F. Toxic effects of halogenated anesthetics on human hepatocytes. Surg. Forum 1975; 26: 422
   PubMedGoogle Scholar
• Cascorbi H. F., Singh Amaranath A. V. Fluroxene toxicity in mice. Anesthesiology 1972; 37: 480
   PubMed Web of Science ®Google Scholar
• Cascorbi H. F., Singh Amaranath A. V. Modification of fluroxene toxicity. Anesthesiology 1973; 38: 454
   PubMed Web of Science ®Google Scholar
• Cascorbi H. F., Gorsky B. H., Redford J. E. Sex differences in anaesthetic toxicity: fluroxene and trifluoroethanol in mice. Br. J. Anaesth. 1976; 48: 399
   PubMed Web of Science ®Google Scholar
• Cascorbi H. F., Gesinski R. M., Komar M. K. Biotransformation, sex hormones, and toxicity of two volatile anesthetics in mice. J. Toxicol. Environ. Health 1976; 1: 839
   PubMed Web of Science ®Google Scholar
• Yoshimura N., Sameshima T., Mivao J. Protective effect of alpha-tocopherol on fluoroxene toxicity in mice (transl.). Masui 1980; 29: 362
   PubMedGoogle Scholar
• Murphy M. J., Piper L. J., Fasco M. J., Cashin M. J., McMartin D. N., Kaminsky L. S. Potentiation of fluroxene (2,2,2-trifluoroethyl vinyl ether) toxicity with polychlorinated biphenyls. Toxicol. Appl. Pharmacol. 1979; 48: 1
   PubMed Web of Science ®Google Scholar
• Murphy M. J., Dunbar D. A., Kaminsky L. S. Role of hepatic microsomal cytochrome P-450 in the toxicity of fluorinated ether anesthetics. Biochem. Pharmacol. 1980; 29: 3257
   PubMed Web of Science ®Google Scholar
• Murphy M. J., Piper L. J., McMartin D. N., Kaminsky L. S. The role of cytochrome P-450-inducing agents in potentiating the toxicity of fluroxene (2,2,2-trifluoroethyl vinyl ether). Toxicol. Appl. Pharmacol. 1980; 52: 69
   PubMed Web of Science ®Google Scholar
• Dersham G., McMartin D., Dunbar D., Kaminsky L. Trifluorinated ether anesthetic lethality in rats: the role of bacterial infection. Toxicol. Appl. Pharmacol. 1983; 71: 93
   PubMed Web of Science ®Google Scholar
• Smith J. S., Harrison G. G. The effects of multiple anaesthetics on the livers of rats subjected to microsomal enzyme induction. A preliminary report. S. Afr. Med. J. 1973; 47: 797
   PubMed Web of Science ®Google Scholar
• Benumof J. L., Wahrenbrock E. A. Local effects of anesthetics on regional hypoxic pulmonary vasoconstriction. Anesthesiology 1975; 43: 525
   PubMed Web of Science ®Google Scholar
• Harrison G. G., Smith J. S. Massive lethal hepatic necrosis in rats anesthetized with fluroxene, after microsomal enzyme induction. Anesthesiology 1973; 39: 619
   PubMed Web of Science ®Google Scholar
• Johnston R. R., Eger E. I., II, Stevens W. C., White P. F. Fluroxene toxicity in dogs: possible mechanisms. Anesth. Analg. 1974; 53: 998
   PubMed Web of Science ®Google Scholar
• Stevens W. C., Eger E. I., II, White A., Biava C. G., Gibbons R. D., Shargel R. Comparative toxicities of enflurane, fluroxene and nitrous oxide at subanaesthetic concentrations in laboratory animals. Can. Anaesth. Soc. J. 1977; 24: 479
   PubMedGoogle Scholar
• Ivanetich K. M., Marsh J. A., Bradshaw J. J., Kaminsky L. S. Fluroxene (2,2,2-trifluoroethyl vinyl ether) mediated destruction of cytochrome P-450 in vitro. Biochem. Pharmacol. 1975; 24: 1933
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Dannan G. A., Wright S. T., Martin M. V., Kaminsky L. S. Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or B-naphthoflavone. Biochemistry 1982; 21: 6019
   PubMed Web of Science ®Google Scholar
• Bradshaw J. J., Ziman M. R., Ivanetich K. M. The degradation of different forms of cytochrome P-450 in vivo by fluroxene and allyl-iso-propylacetamide. Biochem. Biophys. Res. Commun. 1978; 85: 859
   PubMed Web of Science ®Google Scholar
• Ivanetich K. M., Ziman M. R., Bradshaw J. J. Reaction schemes for the degradation of cytochromes P-450 by allyl-isopropylacetamide and fluroxene. Biochem. Pharmacol. 1980; 29: 2805
   PubMed Web of Science ®Google Scholar
• Ivanetich K. M., Ziman M. R., Bradshaw J. J. Reaction schemes for the degradation of cytochrome P-450 by allyl-iso-propylacetamide and fluroxene. Adv. Exp. Med. Biol 1981; 136: 1213
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano P. R., Kunze K. L., Beilan H. S., Wheeler C. Destruction of cytochrome P-450 by vinyl fluoride, fluroxene, and acetylene. Evidence for a radical intermediate in olefin oxidation. Biochemistry 1982; 21: 1331
   PubMed Web of Science ®Google Scholar
• Adams S. M., Murphy M. J., Kaminsky L. S. Molecular orbital studies of the metabolism of fluroxene and analogous fluorinated ether anesthetics. Mol. Pharmacol. 1981; 20: 423
   PubMed Web of Science ®Google Scholar
• Ziman M. R., Bradshaw J. J., Ivanetich K. M. The effect of fluroxene [(2,2,2-trifluoroethoxy)ethane] on haem biosynthesis and degradation. Biochem. J. 1980; 190: 571
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Covalent binding to apoprotein is a major fate of heme in a variety of reactions in which cytochrome P-450 is destroyed. Biochem. Biophys. Res. Commun. 1986; 138: 193
   PubMed Web of Science ®Google Scholar
• Cohen E. N., Brown B. W., Bruce D. L. Occupational disease among operating room personnel: a national study, report of an Ad Hoc Committee on the Effect of Trace Anesthetics on the Health of Operating Room Personnel. Anesthesiology 1974; 41: 321
   PubMed Web of Science ®Google Scholar
• Baden J. M., Simmon V. F. Mutagenic effects of inhalational anesthetics. Mutat. Res. 1980; 75: 169
   PubMed Web of Science ®Google Scholar
• Baden J. M., Kelley M., Wharton R. S., Hitt B. A., Mazze R. I. Mutagenicity of fluroxene [letter]. Anesthesiology 1976; 45: 695
   PubMed Web of Science ®Google Scholar
• Baden J. M., Kelley M., Wharton R. S., Hitt B. A., Simmon V. F., Mazze R. I. Mutagenicity of halogenated ether anesthetics. Anesthesiology 1977; 46: 346
   PubMed Web of Science ®Google Scholar
• Baden J. M., Kelley M., Simmon V. F., Rice S. A., Mazze R. I. Fluroxene mutagenicity. Mutat. Res. 1978; 58: 183
   PubMed Web of Science ®Google Scholar
• White A. E., Takehisa S., Eger E. I., II, Wolff S., Stevens W. C. Sister chromatid exchanges induced by inhaled anesthetics. Anesthesiology 1979; 50: 426
   PubMed Web of Science ®Google Scholar
• Kundomal Y. R., Baden J. M. Mutagenicity of inhaled anesthetics inDrosophila melanogaster. Anesthesiology 1985; 62: 305
   PubMed Web of Science ®Google Scholar
• Husum B., Wulf H. C., Niebuhr E. Sister chromatid exchanges in human lymphocytes after anaesthesia with fluroxene. Br. J. Anaesth. 1982; 54: 987
   PubMed Web of Science ®Google Scholar
• Mathieu A., DiPadua D., Mills J., Kahan B. Experimental immunity to a metabolite of halothane and fluroxene: cutaneous delayed-type hypersensitivity. Anesthesiology 1974; 40: 385
   PubMed Web of Science ®Google Scholar
• Mathieu A., Di Padua D., Kahan B. D., Mills J. Humoral immunity to a metabolite of halothane, fluroxene, and enflurane. Anesthesiology 1975; 42: 612
   PubMed Web of Science ®Google Scholar
• Gandolfi A. J., Sipes I. G., Brown B. R., Jr. Detection of covalently bound halothane metabolites in the hypoxic rat model for halothane hepatotoxicity. Fundam. Appl. Toxical. 1981; 1: 255
   PubMedGoogle Scholar
• Satoh H., Fukuda Y., Anderson D. K., Ferrans V. J., Gillette J. R., Pohl L. R. Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes. J. Pharmacol. Exp. Ther. 1985; 233: 857
   PubMed Web of Science ®Google Scholar
• Soltis J. J., Gandolfi A. J. Detection of fluorinated anesthetic metabolities by sodium fusion. Anesth. Analg. 1980; 59: 61
   PubMed Web of Science ®Google Scholar
• Siadat-Pajouh M., Hubbard A. K., Roth T. P., Gandolfi A. J. Generation of halothane-induced immune response in a guinea pig model of halothane hepatitis. Anesth. Analg. 1987; 66: 1209
   PubMed Web of Science ®Google Scholar
• Gandolfi A. J., White R. D., Sipes I. G., Pohl L. R. Bioactivation and covalent binding of halothane in vitro. Studies with [3H] and [14C]-halothane. J. Pharmacol. Exp. Ther. 1980; 214: 721
   PubMed Web of Science ®Google Scholar
• Gourlay G. K., Adams J. F., Cousins M. J., Hall P. Genetic differences in reductive metabolism and hepatotoxicity of halothane in three rat strains. Anesthesiology 1981; 55: 90
   Web of Science ®Google Scholar
• Trudell J. R., Bosterling B., Trevor A. J. Reductive metabolism of halothane by human and rabbit cytochrome P-450. Binding of 1-chloro-2,2,2-trifluoroethyl radical to phospholipids. Mol. Pharmacol. 1982; 21: 710
   PubMed Web of Science ®Google Scholar
• Ahr H. J., King L. J., Nastainczyk W., Ullrich V. The mechanism of reductive dehalogenation of halothane by liver cytochrome P-450. Biochem. Pharmacol. 1982; 31: 383
   PubMed Web of Science ®Google Scholar
• Cohen E. N., Trudell J. R., Edmunds H. N., Watson E. Urinary metabolites of halothane in man. Anesthesiology 1975; 43: 392
   PubMed Web of Science ®Google Scholar
• Karashima D., Hirokata Y., Shigematsu A., Furukama T. The in vitro metabolism of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) by hepatic microsomal cytochrome P-450. J. Pharmacol. Exp. Ther. 1977; 203: 409
   PubMed Web of Science ®Google Scholar
• Sipes I. G., Gandolfi A. J., Pohl L. R., Krishna G., Brown B. R. Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane. J. Pharmacol. Exp. Ther. 1980; 214: 716
   PubMed Web of Science ®Google Scholar
• Muller R., Stier A. Modification of liver microsomal lipids by halothane metabolites: a multi nuclear NMR spectroscopic study. Naunyn Schnriedebergs Arch. Pharmacol. 1982; 321: 234
   PubMed Web of Science ®Google Scholar
• Airaksinen M. M., Tammisto T. Toxic actions of the metabolites of halothane: LD50 and some metabolic effects of trifluoroethanol and trifluoroacetic acid in mice and guinea pigs. Ann. Med. Exp. Biol. Fenn. 1968; 46: 242
   PubMedGoogle Scholar
• Fraser J. M., Silkworth J. B., Kaminsky L. S. Mechanism of toxicity of 2,2,2-trifluoroethanol in rats. Toxicol. Appl. Pharmacol 1986; 84: 84
   PubMed Web of Science ®Google Scholar
• Kim J. C. S., Fraser J. M., Samsonoff W. A., Kaminsky L. S., Shin S. J. 2,2,2-Trifluoroethanol-induced enteropathy in rats: chemically or bacterially mediated effects. Toxicol. Palhol 1987; 15: 388
   PubMed Web of Science ®Google Scholar
• Marshall T. C., Hahn F. F., Merickel B. S., Hobbs C. H. Ocular toxicity of 2,2,2-trifluoroethanol in rabbits. Fundam. Appl. Toxicol. 1981; 1: 313
   PubMedGoogle Scholar
• Rosenberg P. H., Wahlstrom T. Hepatotoxicity of halothane metabolites in vivo and inhibition of fibroblast growth in vitro. Acta Pharmacol. Toxicol. (Copenhagen) 1971; 29: 9
   PubMedGoogle Scholar
• Sullivan J. L., Smith F. A., Wilkenfeld R. M., Gorman R. H., Kostyniak P. J. Monofluoroacetate and trifluoroethanol as testicular poisons in the rat. Toxicol. Appl. Pharmacol. 1978; 45: 291, (A166)
   Web of Science ®Google Scholar
• Lloyd S. C., Blackburn D. M., Foster P. M. D. Trifluoroethanol and its oxidative metabolites: comparison of in vivo and in vitro effects in rat testis. Toxicol. Appl. Pharmacol. 1988; 92: 390
   PubMed Web of Science ®Google Scholar
• Blake D. A., DiBlasi M. C., Gordon G. B. Absence of mutagenic activity of trifluoroethanol and its metabolites inSalmonella typhimurium. Fundam. Appl. Toxicol. 1981; 1: 415
   PubMedGoogle Scholar
• Rosenberg P. H. Decrease in reduced glutathione and NADPH and inhibition of glucose-6-phosphate dehydrogenase activity caused by metabolites of fluroxene and halothane. Ann. Med. Exp. Biol. Fenn. 1971; 49: 84
   PubMedGoogle Scholar
• , unpublished data
   Google Scholar
• , unpublished data
   Google Scholar